{"id":62111,"date":"2025-10-29T22:02:41","date_gmt":"2025-10-29T21:02:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/"},"modified":"2025-10-29T22:02:41","modified_gmt":"2025-10-29T21:02:41","slug":"enpro-declares-regular-quarterly-dividend","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/","title":{"rendered":"Enpro Declares Regular Quarterly Dividend"},"content":{"rendered":"
\n

CHARLOTTE, N.C.–(BUSINESS WIRE)–Enpro Inc. (NYSE: NPO) today declared a quarterly dividend of $0.31 per share. The dividend is payable on December 17, 2025, to shareholders of record as of the close of business on December 3, 2025.<\/p>\n

<\/a>
<\/a><\/p>\n

\nAbout Enpro<\/b><\/p>\n

\nEnpro is a leading industrial technology company focused on critical applications across many end-markets, including semiconductor, industrial process, commercial vehicle, sustainable power generation, aerospace, food and pharma, photonics and life sciences. Headquartered in Charlotte, North Carolina, Enpro is listed on the New York Stock Exchange under the symbol \u201cNPO\u201d. For more information about Enpro, visit the company\u2019s website at http:\/\/www.enpro.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contacts:<\/b>
James Gentile
\n
Vice President, Investor Relations<\/p>\n

\nJenny Yee
\n
Corporate Access Specialist<\/p>\n

\nPhone: <\/b>704-731-1527<\/p>\n

\nEmail: <\/b>investor.relations@enpro.com<\/a><\/p>\n

\nEnpro Inc.<\/b>
5605 Carnegie Boulevard
\n
Charlotte, NC 28209
\n
www.enpro.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CHARLOTTE, N.C.–(BUSINESS WIRE)–Enpro Inc. (NYSE: NPO) today declared a quarterly dividend of $0.31 per share. The dividend is payable on December 17, 2025, to shareholders of record as of the close of business on December 3, 2025. About Enpro Enpro is a leading industrial technology company focused on critical applications across many end-markets, including semiconductor, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62111","6":"format-standard","7":"category-industry"},"yoast_head":"\nEnpro Declares Regular Quarterly Dividend - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Enpro Declares Regular Quarterly Dividend - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHARLOTTE, N.C.–(BUSINESS WIRE)–Enpro Inc. (NYSE: NPO) today declared a quarterly dividend of $0.31 per share. The dividend is payable on December 17, 2025, to shareholders of record as of the close of business on December 3, 2025. About Enpro Enpro is a leading industrial technology company focused on critical applications across many end-markets, including semiconductor, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-29T21:02:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251029963893\/en\/1062268\/22\/Enpro-Horiztonal-CMYK-01.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-declares-regular-quarterly-dividend\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-declares-regular-quarterly-dividend\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Enpro Declares Regular Quarterly Dividend\",\"datePublished\":\"2025-10-29T21:02:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-declares-regular-quarterly-dividend\\\/\"},\"wordCount\":138,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-declares-regular-quarterly-dividend\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251029963893\\\/en\\\/1062268\\\/22\\\/Enpro-Horiztonal-CMYK-01.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-declares-regular-quarterly-dividend\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-declares-regular-quarterly-dividend\\\/\",\"name\":\"Enpro Declares Regular Quarterly Dividend - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-declares-regular-quarterly-dividend\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-declares-regular-quarterly-dividend\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251029963893\\\/en\\\/1062268\\\/22\\\/Enpro-Horiztonal-CMYK-01.jpg\",\"datePublished\":\"2025-10-29T21:02:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-declares-regular-quarterly-dividend\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-declares-regular-quarterly-dividend\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-declares-regular-quarterly-dividend\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251029963893\\\/en\\\/1062268\\\/22\\\/Enpro-Horiztonal-CMYK-01.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251029963893\\\/en\\\/1062268\\\/22\\\/Enpro-Horiztonal-CMYK-01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enpro-declares-regular-quarterly-dividend\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Enpro Declares Regular Quarterly Dividend\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enpro Declares Regular Quarterly Dividend - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/","og_locale":"en_US","og_type":"article","og_title":"Enpro Declares Regular Quarterly Dividend - Pharma Trend","og_description":"CHARLOTTE, N.C.–(BUSINESS WIRE)–Enpro Inc. (NYSE: NPO) today declared a quarterly dividend of $0.31 per share. The dividend is payable on December 17, 2025, to shareholders of record as of the close of business on December 3, 2025. About Enpro Enpro is a leading industrial technology company focused on critical applications across many end-markets, including semiconductor, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/","og_site_name":"Pharma Trend","article_published_time":"2025-10-29T21:02:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251029963893\/en\/1062268\/22\/Enpro-Horiztonal-CMYK-01.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Enpro Declares Regular Quarterly Dividend","datePublished":"2025-10-29T21:02:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/"},"wordCount":138,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251029963893\/en\/1062268\/22\/Enpro-Horiztonal-CMYK-01.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/","url":"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/","name":"Enpro Declares Regular Quarterly Dividend - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251029963893\/en\/1062268\/22\/Enpro-Horiztonal-CMYK-01.jpg","datePublished":"2025-10-29T21:02:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251029963893\/en\/1062268\/22\/Enpro-Horiztonal-CMYK-01.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251029963893\/en\/1062268\/22\/Enpro-Horiztonal-CMYK-01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/enpro-declares-regular-quarterly-dividend\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Enpro Declares Regular Quarterly Dividend"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62111","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62111"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62111\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62111"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62111"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62111"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}